Liquidia Corp (LQDA)
10.00
-0.02
(-0.25%)
USD |
NASDAQ |
Nov 15, 13:51
Liquidia Gross Profit (Annual): 14.60M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.60M |
| December 31, 2022 | 13.08M |
| December 31, 2021 | 9.83M |
| December 31, 2020 | 0.5019M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.265M |
| December 31, 2018 | 2.586M |
| December 31, 2017 | 6.938M |
| December 31, 2016 | 12.30M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.5019M
Minimum
2020
14.60M
Maximum
2023
9.055M
Average
9.83M
Median
2021
Gross Profit (Annual) Benchmarks
| United Therapeutics Corp | 2.07B |
| Arcturus Therapeutics Holdings Inc | -- |
| Paragon 28 Inc | 164.44M |
| Tonix Pharmaceuticals Holding Corp | 3.027M |
| AIM ImmunoTech Inc | 0.16M |